Alpine Clinical Research Center

Main menu

Skip to content
  • Home
  • Current Research Studies
  • For Participants
  • For Sponsors
  • Contact

Trial Archives: Completed

Post navigation

← Older trials

Eli Lilly, TRIUMPH-7 (Obesity/Overweight & Chronic Low Back Pain): A Study to Investigate Efficacy and Safety of Retatrutide Once Weekly in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

- November 19, 2025

Avadel, REVITALYZ (Idiopathic Hypersomnia): A Double-blind, Placebo-controlled, Randomized Withdrawal, Multicenter Study of the Efficacy and Safety of FT218 in the Treatment of Idiopathic Hypersomnia (IH)

- October 29, 2024

Alzheimer’s Study

- August 26, 2022

Narcolepsy Type 2 Study

- April 13, 2022

Narcolepsy Type 1 with Cataplexy

- April 13, 2022

Narcolepsy Type 1 With Cataplexy

- April 13, 2022

Idiopathic Hypersomnia Study

- April 13, 2022

Acute Migraine Treatment Study

- April 1, 2022

COPD Studies

- April 1, 2022

Observational Study in Patients with Parkinson’s Disease

- September 26, 2018

Investigational Medication for people with Relapsing Remitting Multiple Sclerosis

- September 26, 2018

Idiopathic Hypersomnia Study

- July 25, 2018

Narcolepsy Type 1 Studies

- July 25, 2018

Asthma Research Study

- July 16, 2018

New investigational treatment in migraine prevention

- January 8, 2018

Post navigation

← Older trials

Our CenterWatch Profile

Alpine Clinical Research Center on CenterWatch

Alpine Clinical Research Center - 3434 47th Street, Suite 201 - Boulder, CO 80301
phone: 303.443.7229 | fax: 303.443.7748 | email: info@alpineresearch.com
site by: Lenfert Design